Literature DB >> 25547930

The benefits and potential drawbacks in the approval of EVZIO for lay reversal of opioid overdose.

Leo Beletsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547930      PMCID: PMC4339419          DOI: 10.1016/j.amepre.2014.09.011

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  6 in total

1.  Easy-to-use overdose antidote earns fast-track approval.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

2.  Using a drug-safety tool to prevent competition.

Authors:  Ameet Sarpatwari; Jerry Avorn; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2014-04-17       Impact factor: 91.245

3.  Project Lazarus: community-based overdose prevention in rural North Carolina.

Authors:  Su Albert; Fred W Brason; Catherine K Sanford; Nabarun Dasgupta; Jim Graham; Beth Lovette
Journal:  Pain Med       Date:  2011-06       Impact factor: 3.750

4.  CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-13       Impact factor: 17.586

5.  Prevention of fatal opioid overdose.

Authors:  Leo Beletsky; Josiah D Rich; Alexander Y Walley
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

6.  Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-02-17       Impact factor: 17.586

  6 in total
  2 in total

1.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

Review 2.  Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.

Authors:  Jamie K Lim; Jeffrey P Bratberg; Corey S Davis; Traci C Green; Alexander Y Walley
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.